UBS Group Portfolio holdings
UBS Group AG, formed through the 1998 merger of Union Bank of Switzerland and Swiss Bank Corporation with roots dating back to 1862, is a Swiss multinational investment bank and financial services firm headquartered in Zurich. Renowned for its dominance in wealth management, UBS serves high-net-worth individuals and families globally, managing trillions in assets, while also offering investment banking, asset management, and retail banking services in Switzerland. The firm has weathered significant challenges, including a major bailout during the 2008 financial crisis, but has since refocused on stability and sustainable growth, emphasizing digital transformation and ESG (environmental, social, governance) investing. With a strong European base and a global reach, UBS remains a cornerstone of the international financial landscape.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.26B |
| 2 |
Strategy Inc
MSTR
|
+$745M |
| 3 |
EA
Electronic Arts
EA
|
+$725M |
| 4 |
TotalEnergies
TTE
|
+$639M |
| 5 |
Walmart Inc
WMT
|
+$585M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.87B |
| 2 |
Apple
AAPL
|
+$1.41B |
| 3 |
Microsoft
MSFT
|
+$1.16B |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$1.03B |
| 5 |
Southwest Airlines
LUV
|
+$727M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.52% |
| 2 | Financials | 9.54% |
| 3 | Healthcare | 6.68% |
| 4 | Industrials | 6.61% |
| 5 | Consumer Discretionary | 6.41% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
5901
JPMorgan Diversified Return Emerging Markets Equity ETF
JPEM
$390M
| $631K | ﹤0.01% |
10,395
+1,327
| +15% | +$79.7K |
|
5902
Health Catalyst
HCAT
$139M
| $630K | ﹤0.01% |
263,487
+66,173
| +34% | +$181K |
|
5903
Manitowoc
MTW
$746M
| $629K | ﹤0.01% |
52,438
-331,624
| -86% | -$3.77M |
|
|
API
5904
Agora
API
$392M
| $629K | ﹤0.01% |
154,448
-95,339
| -38% | -$350K |
|
5905
CVRx
CVRX
$82.1M
| $628K | ﹤0.01% |
88,401
-62,922
| -42% | -$574K |
|
5906
WisdomTree Emerging Markets Local Debt Fund
ELD
$143M
| $626K | ﹤0.01% |
21,442
+2,546
| +13% | +$73.4K |
|
5907
Black Diamond Therapeutics
BDTX
$116M
| $626K | ﹤0.01% |
257,633
-370,783
| -59% | -$1.31M |
|
5908
Civista Bancshares
CIVB
$593M
| $626K | ﹤0.01% |
28,171
-182,568
| -87% | -$4.03M |
|
|
NEWP
5909
New Pacific Metals
NEWP
$1.27B
| $625K | ﹤0.01% |
178,000
+169,776
| +2,064% | +$465K |
|
|
SCD
5910
LMP Capital and Income Fund
SCD
$363M
| $625K | ﹤0.01% |
42,176
+32,417
| +332% | +$483K |
|
5911
Global X Genomics & Biotechnology ETF
GNOM
$85.4M
| $624K | ﹤0.01% |
13,727
-2,557
| -16% | -$113K |
|
5912
CALL
Eagle Materials
EXP
$6.4B
| $620K | ﹤0.01% |
3,000
| – | – |
|
|
TOPT
5913
iShares Top 20 U.S. Stocks ETF
TOPT
$679M
| $620K | ﹤0.01% |
19,844
+19,544
| +6,515% | +$606K |
|
|
VTYX
5914
DELISTED
Ventyx Biosciences
VTYX
| $616K | ﹤0.01% |
68,216
-459,076
| -87% | -$3.43M |
|
|
PDT
5915
John Hancock Premium Dividend Fund
PDT
$628M
| $613K | ﹤0.01% |
48,234
-13,485
| -22% | -$175K |
|
|
URG
5916
Ur-Energy
URG
$537M
| $612K | ﹤0.01% |
440,541
-95,706
| -18% | -$142K |
|
5917
Virco
VIRC
$95.2M
| $612K | ﹤0.01% |
95,808
+19,310
| +25% | +$134K |
|
5918
AC Immune
ACIU
$253M
| $610K | ﹤0.01% |
194,349
+177,925
| +1,083% | +$561K |
|
|
DFNS
5919
T3 Defense Inc
DFNS
$34.1M
| $609K | ﹤0.01% |
1,208
+564
| +88% | +$464K |
|
5920
Bioventus
BVS
$1.2B
| $608K | ﹤0.01% |
81,665
+9,705
| +13% | +$69.8K |
|
5921
CALL
Global X Copper Miners ETF NEW
COPX
$7.98B
| $605K | ﹤0.01% |
8,428
+3,740
| +80% | +$240K |
|
5922
SR Bancorp
SRBK
$146M
| $604K | ﹤0.01% |
38,355
+12,794
| +50% | +$196K |
|
5923
PUT
Hilton Worldwide
HLT
$73.6B
| $603K | ﹤0.01% |
2,100
| – | – |
|
|
HSHP
5924
Himalaya Shipping
HSHP
$760M
| $600K | ﹤0.01% |
65,987
-70,073
| -52% | -$592K |
|
|
CVGW
5925
DELISTED
Calavo Growers
CVGW
| $600K | ﹤0.01% |
27,586
-41,915
| -60% | -$930K |
|
Similar funds
UBS Group's Q4 2025 Portfolio in Review
As of Q4 2025, UBS Group held 11,616 positions worth $617B, down 3.4% from $638B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
UBS Group withdrew a net $32.7B in Q4 2025, closing 1,184 positions and reducing 4,502 holdings. Its most notable exit was Kellanova, an estimated $617M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
Against the trend, UBS Group opened a new position in Solstice Advanced Materials worth $130M.
- UBS Group's largest Q4 2025 buy was Solstice Advanced Materials: 2,681,543 shares worth $130M.
- UBS Group added most to State Street SPDR S&P 500 ETF Trust in Q4 2025, an estimated $1.26B increase.
- UBS Group's biggest Q4 2025 reduction was NVIDIA, cutting an estimated $1.87B.
- UBS Group fully exited Kellanova in Q4 2025, selling an estimated $617M.
- UBS Group's ten largest holdings make up 15% of its $617B portfolio in Q4 2025.
- UBS Group opened 1,319 new positions and closed 1,184 in Q4 2025.
- UBS Group's portfolio value fell 3.4% quarter-over-quarter to $617B.
Based on UBS Group's 13F filing for Q4 2025, filed 29 Jan 2026.